
But what about AI firms that have yet to go public? That's where all the action seems to be, as companies like OpenAI attract the world's top venture capital firms with record-breaking funding rounds—a process that mostly excludes everyday investors.
Venture capitalists may have the inside track when it comes to the likes of OpenAI, but the coming months are still poised to offer other intriguing new AI investments. Not only are more AI startups ready for the big time, but after a spell when uncertain economic conditions forced firms to stay private, a new era of public offerings is underway. Dzung Nguyen, a Wells Fargo banker, says she expects the tide to shift in the coming months, even if we don't see the frenzied action of 2021 when a rash of firms went public, often at implausible valuations.
WHO COULD GO PUBLIC?
Stock pickers can expect a handful of late-stage AI companies to test the IPO waters this year, with some already close to listing. Those include Cerebras, a California-based chipmaker competing against mighty Nvidia. Even though Cerebras is dwarfed by Jensen Huang's chip behemoth, it has a huge opportunity for growth as firms of all sorts scramble for hardware to power their AI ambitions. But its expansion plans face an impediment: a national security review related to a proposed United Arab Emirates-backed investment. Cerebras declined to comment, but investors have expressed measured confidence it will go through.
Another AI native gearing up for an IPO is CoreWeave, a cloud-computing company, which is reportedly targeting a $35 billion public offering in 2025. Joe Endoso, president of investment platform Linqto, says that CoreWeave's data center services are necessary for companies building bespoke AI applications. “It’s the difference between buying a sports car and an everyday sedan,” he says.
Esta historia es de la edición February - March 2025 de Fortune US.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición February - March 2025 de Fortune US.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar

The Blackstone Edge
90 DAYS. DOZENS OF INTERVIEWS. BILLIONS ON THE LINE. HOW BLACKSTONE'S CEO-MAKER GETS THE JOB DONE.

When Elon Musk has a really tough job, he turns to Steve Davis. DOGE might do the same.
IT WAS THE FALL OF 2022 when employees at Elon Musk's Boring Company began to notice Steve Davis wasn't around.

ASK ANDY - SHOULD MY STARTUP RAISE MONEY FROM VCS? IF SO, WHICH ONES DO I CHOOSE?
A FRIEND—I’ll call him Allen—spent years bootstrapping his real estate enterprise software company. After a long struggle to get to $1 million in sales, his business recently surged to $10 million, and revenue is now growing 100% year on year.

ELLIOTT HILL - JUST DOING IT
Staffers and brand loyalists cheered when Nike's new CEO came out of retirement to lead the company he has had an “irrational love” for since he began there as an intern. Turning it around will take more than good vibes.

HOW TO PLAN YOUR NEXT $100,000 VACATION
ON AN EXCURSION to the ancient city of Petra, Jordan, clients helicoptered in after-hours so they could tour the ruins alone.

THE BATTLE OVER AG1
Influencers are fighting over it. Scientists scoff at it. But the $100-a-month powder once known as Athletic Greens is only getting more popular.

THE WORKPLACE - GEN ZERS WANT TO BE THEIR OWN BOSS.CAN THE CORPORATE WORLD WOO THEM BACK?
CHASE GALLAGHER WAS 12 years old when he started mowing his neighbors' lawns in Chester County, Pa., for $35 a pop in the summer of 2013. At first the Gen Zer had only two customers, but thanks to some aggressive leafleting, he had 10 clients by the following year.

How much can DOGE do?
Elon Musk and Donald Trump aim to cut as much as $2 trillion in federal spending. It'll be even harder than it sounds.

YOUNG PEOPLE ARE DRINKING LESS ALCOHOL. CAN CEO MICHEL DOUKERIS PERSUADE THEM TO KEEP DRINKING AB INBEV'S BEERS?
SOME TIME AGO, top CEOs at an invitation-only seminar at Harvard Business School were asked to imagine the four crises they would likely confront during their tenure at the top: a health emergency, a geopolitical conflict, an economic downturn, and a trade war.

America's drug middlemen are now a $557 billion industry. Can Trump and his allies 'knock out' PBMs?
IN LATE DECEMBER, President-elect Donald Trump put pharmacy benefit managers, or PBMs, on notice.